comprehensive -WSS

comprehensive

author：entertainment 2025-10-02 15:43:25 - browse：48931

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Kale crackers and hibiscus tea: My five days on a 'fasting diet'

WSS

Medical device lobby: We're tired of waiting on Medicare coverage

Kenai launches with $82 million for Parkinson’s stem cell therapy

How to address the problem of discarded donor organs

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Physicians aren't 'burning out.' They're suffering from moral injury

When waiting feels immoral: Empathy in the emergency department

entertainment

comprehensive

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

Why getting cancer drugs just got harder for rural patients

Novavax promises a turnaround & Lilly roils the obesity market

It costs an awful lot of money to give away a kidney

State Dept. review finds Biden bears some blame for Afghanistan failures

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

Guidelines to prevent youth baseball injuries need more muscle

Medicare slashes safety net hospital payments by nearly $1 billion

Activists slam private health insurers over coverage restrictions

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

leisure time

Covid isolation guidance eased by the CDC

Study links childhood stress with decline in older age

Chris Christie meets with Zelenskyy during Ukraine trip

When waiting feels immoral: Empathy in the emergency department

AstraZeneca loses challenge to Medicare drug price negotiation

Pfizer highlights cancer drugs it thinks could reignite investor interest

Wikipedia

leisure time

entertainment

focus